SFCL
KLRS

Strengthening Families & Communities LLC’s Kalaris Therapeutics KLRS Stock Holding History

Strengthening Families & Communities LLC’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.55K Buy
+268
New +$2.38K ﹤0.01% 526
2025
Q4 		– Sell
-268
Closed -$1.55K – 765
2025
Q3 		$1.55K Buy
+268
New +$886 ﹤0.01% 519
2024
Q4 		– Sell
-270
Closed -$5.01K – 580
2024
Q3 		$5.01K Hold
270
– – ﹤0.01% 388
2024
Q2 		$4K Hold
270
– – ﹤0.01% 438
2024
Q1 		$5K Hold
270
– – ﹤0.01% 185
2023
Q4 		$4.21K Hold
270
– – ﹤0.01% 184
2023
Q3 		$13K Hold
270
– – 0.01% 297
2023
Q2 		$21K Hold
270
– – 0.01% 295
2023
Q1 		$24 Buy
+270
New +$34.4K ﹤0.01% 190

Other funds holding KLRS

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Strengthening Families & Communities LLC's KLRS Position: Q1 2026 in Review

Strengthening Families & Communities LLC opened a new position in Kalaris Therapeutics (KLRS) in Q1 2026: 268 shares worth $1.55K. The stake represents ﹤0.01% of the portfolio and ranks #526 among its holdings. This is a return to the name: Strengthening Families & Communities LLC previously reported a position in KLRS as recently as Q3 2025.

Strengthening Families & Communities LLC first reported a position in KLRS in Q1 2023 and has held it in 9 quarters since. The position peaked at $21K in Q2 2023. 58 funds tracked by Wall St. Rank hold KLRS as of Q1 2026.

  • Strengthening Families & Communities LLC held 268 shares of Kalaris Therapeutics worth $1.55K as of Q1 2026.
  • Kalaris Therapeutics was a new Strengthening Families & Communities LLC position in Q1 2026.
  • Kalaris Therapeutics made up ﹤0.01% of Strengthening Families & Communities LLC's portfolio in Q1 2026, its #526 holding.
  • Strengthening Families & Communities LLC first reported a position in Kalaris Therapeutics in Q1 2023 and has held it in 9 quarters since.
  • Strengthening Families & Communities LLC's Kalaris Therapeutics position peaked at $21K in Q2 2023.
  • 58 funds tracked by Wall St. Rank held Kalaris Therapeutics as of Q1 2026.

Based on Strengthening Families & Communities LLC's 13F filing for Q1 2026, filed 11 May 2026.